Navigation Links
Cytos Biotechnology Reports Results from Phase IIa Study with,CYT003-QbG10 in Patients Suffering from Atopic Dermatitis

the treatment of allergic diseases. It consists of the Immunodrug™ QbG10 which is comprised of the virus-like particle Qb filled with a synthetic immunostimulatory DNA sequence called G10. CYT003-QbG10 is designed as a disease-modifying treatment and aims to induce a potent Th1 type immune response in order to suppress an “allergic” Th2 type immune response. An open-label phase IIa study with CYT003-QbG10 combined with an allergen extract of house dust mites at a standard dose showed excellent longterm efficacy in patients allergic to dust mites. Furthermore, two placebo-controlled phase IIa
studies with CYT003-QbG10 monotherapy delivered positive results in patients suffering from grass pollen and house dust mite allergy.

For further information please contact: Cytos Biotechnology AG, Wagistrasse 25, CH-8952 Schlieren (Zurich)
Dr. Claudine Blaser
Director Corporate Communications
Phone: +41 44 733 47 20
Fax: +41 44 733 47 18
e-Mail: claudine.blaser@cytos.com
Website: www.cytos.com

About Cytos Biotechnology
Cytos Biotechnology AG is a public Swiss biotechnology company that specializes in the discovery, development and commercialization of a new class of biopharmaceutical products – the Immunodrugs™. Immunodrugs™ are intended for use in the treatment and prevention of common chronic diseases, which afflict millions of people worldwide. Immunodrugs™ are designed to instruct the patient’s immune system to produce desired therapeutic antibody or T cell responses that modulate chronic disease processes. Taking advantage of the high flexibility of its Immunodrug™ platform, Cytos Biotechnology has built a full pipeline of different Immunodrug™ candidates in various disease areas, of which 6 are currently in clinical developm
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Cytos Reports Results from Phase I/IIa Study with CYT007-TNFQb for the Treatment of Psoriasis
2. Generex Biotechnology to Make Presentations At 46th Annual Meeting of the European Society of Pediatric Endocrinology
3. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ESMO Conference
4. Beike Biotechnology Study Suggests Adult Stem Cells Show Promise for Peripheral Vascular Disease
5. Prana Biotechnology Presents New Key Findings on PBT2
6. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at ASCO Annual Meeting
7. Generex Biotechnology Vaccine Strategy Presented at International Conference in London
8. Cougar Biotechnology Announces Presentation of Positive CB7630 Clinical Data at AUA Annual Meeting
9. Cougar Biotechnology Presents Positive CB7630 Clinical Data at AACR Annual Meeting Late-Breaking Clinical Trials Session
10. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
11. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
Post Your Comments:
(Date:4/27/2015)... JERUSALEM , April 27, 2015 ... successfully completed filing of a Pre-Marketing Notification Application (510k) ... its BRH-A2 Wound Management System. BRH Medical expects feedback ... entering the US market with BRH-A2 following FDA pre-market ... Motti Oderberg , CEO for BRH ...
(Date:4/27/2015)... , April 27, 2015 - ... Process Patent by the State Intellectual Property Office of ... Based on Pooling Technology  - A New Treatment ... (CLI)    - About 20% of Elderly Urban ... in Women is Substantially Higher Than in Men. CLI is ...
(Date:4/26/2015)... April 26, 2015  Ikonopedia announced today that ... system have been selected for use by BelleBridge, ... screening and diagnostic examinations. Ikonopedia will showcase its ... of Breast Imaging,s SBI/ACR Breast Imaging Symposium in ... 2015 (SBI Booth #216). BelleBridge is ...
Breaking Medicine Technology:BRH Medical, Ltd., Announces Filing of a Pre-Market Submission with the US Food and Drug Administration (FDA) for the BRH-A2 Tissue Management System 2Stempeutics Gets Stem Cell Patent in China (Chinese Application Number: CN201080053627) for its Novel Stem Cell Drug 'Stempeucel' 2Stempeutics Gets Stem Cell Patent in China (Chinese Application Number: CN201080053627) for its Novel Stem Cell Drug 'Stempeucel' 3Stempeutics Gets Stem Cell Patent in China (Chinese Application Number: CN201080053627) for its Novel Stem Cell Drug 'Stempeucel' 4Ikonopedia Selected to Provide Breast Imaging Report Generation Capabilities for BelleBridge's Breast Telemedicine Services 2Ikonopedia Selected to Provide Breast Imaging Report Generation Capabilities for BelleBridge's Breast Telemedicine Services 3Ikonopedia Selected to Provide Breast Imaging Report Generation Capabilities for BelleBridge's Breast Telemedicine Services 4
... of human-animal hybrids to generate stem cells WORCESTER, ... Pink Sheets: ACTC) and its collaborators reported today that ... reprogram adult human cells. The research, which appears online ... Stem Cells (Editor-in-Chief: Sir Ian Wilmut; published by ...
... Men who experience erectile dysfunction between the ages of ... disease than men without dysfunction, according to a new Mayo ... have an 80 percent higher risk of heart disease. "The ... says researcher Jennifer St. Sauver, Ph.D. The study was published ...
Cached Medicine Technology:Cloned Human Embryos Successfully Reprogrammed Using Human - But Not Animal - Eggs 2Cloned Human Embryos Successfully Reprogrammed Using Human - But Not Animal - Eggs 3Cloned Human Embryos Successfully Reprogrammed Using Human - But Not Animal - Eggs 4Cloned Human Embryos Successfully Reprogrammed Using Human - But Not Animal - Eggs 5Mayo Clinic Study Finds Younger Men With Erectile Dysfunction at Double Risk of Heart Disease 2Mayo Clinic Study Finds Younger Men With Erectile Dysfunction at Double Risk of Heart Disease 3
(Date:4/27/2015)... (PRWEB) April 27, 2015 Douglas Fitzpatrick ... help his clients feel secure, but also helps secure homes ... 7 p.m., Douglas will be manning a booth at the ... Lausche Building, 717 E. 17th Ave., Columbus, Ohio. , ... event that will feature hundreds of adoptable pets from more ...
(Date:4/27/2015)... April 27, 2015 FMC Corporation’s Health ... its wide range of market leading ingredients and solutions ... in Geneva, Switzerland. Vitafoods Europe 2015 expects to host ... showcasing the latest research in such areas as digestive ... , FMC Health and Nutrition’s booth will feature its ...
(Date:4/27/2015)... 27, 2015 A' Design Award and ... SMRT IMAGE Lumica by Boombang Inc Design Team has ... Design Award in Scientific Instruments, Medical Devices and ... SMRT IMAGE Lumica, Boombang Inc Design Team, the creative ... Lumica explained “SMRT Image Lumica is a two-way communication ...
(Date:4/27/2015)... April 27, 2015 Cannabix Technologies Inc. ... that Mr. Rocco Iannapollo has become an Advisor to ... for law enforcement and workplace testing. Mr. Iannapollo is ... 20 years of experience in the oil and gas ... experience with supplier, employer, and DOT compliance policies and ...
(Date:4/27/2015)... 2015 Ticket Down is a reputable ... Alpine Valley Music Theatre and the Isleta Amphitheater. ... New Mexico area can celebrate because their favorite performer ... Buffett will be performing alongside legendary performers, Huey ... stops during the summer and fall months of 2015 ...
Breaking Medicine News(10 mins):Health News:Farmers Insurance Agent Douglas Fitzpatrick Ensures Pets Find Homes 2Health News:FMC Health and Nutrition to Feature Epax® Brand Omega-3 Ingredients at Vitafoods Europe 2015 2Health News:Boombang Inc Design Team wins Platinum in A' Medical Product Design Awards 2Health News:Rocco Iannapollo becomes an Advisor to Cannabix Technologies 2Health News:Rocco Iannapollo becomes an Advisor to Cannabix Technologies 3Health News:Rocco Iannapollo becomes an Advisor to Cannabix Technologies 4Health News:Cheap Jimmy Buffett Tickets at Alpine Valley Music Theatre in Elkhorn, WI and at Isleta Amphitheater in Albuquerque, NM Now on Sale at TicketDown.com 2
... deficiency is associated with arterial stiffness, a risk factor for ... new study accepted for publication in The Endocrine Society,s www.endo-society.org ... units (IU) per day had a decrease in central arterial ... humans with most of our body,s requirement of vitamin D, ...
... By Steven Reinberg HealthDay Reporter , WEDNESDAY, ... prostate cancer vaccine extended the lives of men with ... study shows. The vaccine, called Provenge (sipuleucel-T), improved ... and involved less toxicity than chemotherapy. However, with a ...
... HealthDay Reporter , WEDNESDAY, July 28 (HealthDay News) -- ... warning of Parkinson,s disease and other neurological disorders, new research ... condition in which people violently act out their dreams during ... to develop Parkinson,s and related neurological disorders as much as ...
... prostate cancer, especially the more aggressive and dangerous forms that ... they age than men who stay free of the disease, ... on Aging (NIA), part of the National Institutes of Health. ... of Urology International , could help scientists gain a better ...
... HealthDay Reporter , TUESDAY, July 27 (HealthDay News) -- The ... their 40s is due more to the technology itself than ... study. For years, experts have known that mammography,s performance ... and they,ve placed much of the blame on the notion ...
... adults are more likely to use walkers, canes and other ... risk of using them incorrectly, according to new research from ... obesity is an epidemic for this population as well," said ... the project,s lead author. "This research shows that if obesity ...
Cached Medicine News:Health News:Vitamin D deficiency linked to arterial stiffness in black teens 2Health News:Vaccine Boosts Survival for Men With Advanced Prostate Cancer: Study 2Health News:Vaccine Boosts Survival for Men With Advanced Prostate Cancer: Study 3Health News:Sleep Disorder May Help Predict Parkinson's Decades Earlier 2Health News:Sleep Disorder May Help Predict Parkinson's Decades Earlier 3Health News:Dense bones linked to raised risk for prostate cancer 2Health News:Technology May Explain Mammogram's Poorer Performance in Younger Women 2Health News:Technology May Explain Mammogram's Poorer Performance in Younger Women 3Health News:Study: Weight issues move up need for walkers, canes, other devices 2Health News:Study: Weight issues move up need for walkers, canes, other devices 3
Micro instruments designed to provide maximum grasping, resecting capability, and excellent maneuverability for easy access to tight, small joints (wrist, elbow, and ankle).,Features pinless hinge d...
... LactoSorb® No-Profile Screw and Washer ... for multiple soft tissue re-attachments ... No-Profile Screw and washer provides ... a standard screw and washer ...
... The Stryker Inter-Lock™ System ... surgery at the tibial fixation ... backup fixation into one implant. ... and can be used routinely ...
The Stryker Bioabsorbable Wedge Interference Screw is made of Poly-L Lactic Acid (PLLA). The patented wedge design makes it perfect for cruciate reconstruction and is indicated for BTB and soft tissu...
Medicine Products: